Report from Extraordinary General Meeting of SaltX Technology Holding AB (publ)

Report this content

At today’s Extraordinary General Meeting of SaltX Technology Holding AB (publ) it was resolved in accordance with the Nomination Committee’s proposals.

The Extraordinary General Meeting passed the following resolutions. All resolutions were in accordance with the proposals submitted, which are described in detail in the meeting documents available on the company’s website, www.saltxtechnology.com.

  • It was resolved that the number of Board members shall be seven.
  • It was resolved on the new election of Per Bodén as Board members for the period until the end of the next Annual General Meeting.
  • It was resolved that the fee to the Chairman of the Board shall be SEK 405,000 and that the fee to other general meeting-elected Board members shall be SEK 135,000 each. It was resolved that no special fee shall be paid for committee work. The fees to the Board of Directors remain unchanged in relation to the resolution at the company’s Annual General Meeting 2022, with the adjustment that an additional annual Board fee will be paid to the newly elected member of the Board of Directors; however, that such annual fee will be paid pro rata in relation to the length of the assignment period.

For further information, please contact:

Åke Sund, Chairman of the Board, tel: +46 70-667 00 74

Carl-Johan Linér, CEO, tel: +46 705-32 08 08

********************************************  

About SaltX Technology
SaltX Technology is a Swedish GreenTech company that develops and markets sustainable technology that benefits customers, the climate, and society. The company operates in large-scale energy storage solutions and electrification technology for mainly the lime and cement industry. SaltX Technology's share is listed on the Nasdaq First North Premier Growth Market. FNCA Sweden AB, + 468-528 00 399, info@fnca.se is SaltX Technology's certified advisor. For more information, visit www.saltxtechnology.com.

Subscribe

Documents & Links